PIRAMAL PHARMA
Back to Cashflow Statement
|
PIRAMAL PHARMA Last 5 Year Cash Flow from Investing Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Investing Activities | ₹-826 Cr | ₹-477 Cr | ₹-434 Cr | ₹-1,339 Cr | ₹-1,812 Cr |
What is the latest Cash Flow from Investing Activities ratio of PIRAMAL PHARMA ?
| Year | Cash Flow from Investing Activities |
|---|---|
| Mar2026 | ₹-826 Cr |
| Mar2025 | ₹-477 Cr |
| Mar2024 | ₹-434 Cr |
| Mar2023 | ₹-1,339 Cr |
| Mar2022 | ₹-1,812 Cr |
How is Cash Flow from Investing Activities of PIRAMAL PHARMA Trending?
| Years | Cash Flow from Investing Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹-826 Cr | Negative | |
| Mar2025 | ₹-477 Cr | Negative | |
| Mar2024 | ₹-434 Cr | Negative | |
| Mar2023 | ₹-1,339 Cr | Negative | |
| Mar2022 | ₹-1,812 Cr | - | |
Compare Cash Flow from Investing Activities of peers of PIRAMAL PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| PIRAMAL PHARMA | ₹25,807.3 Cr | -3.2% | -7.7% | 0.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹419,620.0 Cr | -0.8% | -5.1% | 6.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹239,714.0 Cr | -3.2% | -1.4% | 53.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹174,741.0 Cr | -1.6% | -6% | 32.1% | Stock Analytics | |
| CIPLA | ₹106,061.0 Cr | 0% | -3.6% | -13.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,339.0 Cr | 3.1% | 8.7% | -1.5% | Stock Analytics | |
PIRAMAL PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| PIRAMAL PHARMA | -3.2% |
-7.7% |
0.5% |
| SENSEX | 0.2% |
-2.8% |
-11.2% |
You may also like the below Video Courses